Solventum Rebounds From Pullback as Uptrend Gains MomentumSolventum CorporationBATS:SOLVfinvestnomicsSOLV is attracting buying pressure following its recent retracement, with the stock rebounding strongly and confirming its uptrend. It continues to make higher highs and higher lows while trading above its well-aligned 20- and 50-day moving averages. Solventum Corp. is a $13.77 billion market-cap healthcare company that provides innovative solutions across medical, surgical, dental, health information systems, and biopharma filtration markets. The company focuses on improving patient outcomes, enhancing healthcare efficiency, and advancing clinical technologies. SOLV is a narrow-moat company that has grown revenue in one of the last three quarters and increased earnings per share in two of the last three quarters. Operating and net margins stand at 6% and 1%, respectively, while return on equity and return on invested capital are 35% and 14%. The company maintains a current ratio of 1.1x and a debt-to-equity ratio of 1.1x.